CLINSQUARE: CLINICAL RESEARCH COURSES
Thursday, January 23, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

U.S. FDA approved priority review to sNDA for Braftovi® (encorafenib) in combination with erbitux® (cetuximab) (braftovi doublet) for the treatment of Brafv600e-mutant metastatic colorectal...

admin - 0
Latest Pharma-News

Galapagos in collaboration with Gilead submits NDA to U.S. Food and Drug Administration under priority review for filgotinib for rheumatoid arthritis treatment

admin - 0
Latest Pharma-News

Oxidien Pharmaceuticals Announces encouraging Response from FDA on Proposed Development Plan

admin - 0
Latest Pharma-News

Bristol-Myers Squibb Announces Submission of Biologics License Application to the U.S. Food and Drug Administration (FDA) for CAR T-Cell Therapy Lisocabtagene Maraleucel (liso-cel)

admin - 0
Latest Pharma-News

FDA Grants Accelerated Approval to Astellas’ and Seattle Genetics’ PADCEV™ (enfortumab vedotin-ejfv) for the treatment of locally Advanced or Metastatic Urothelial Cancer

admin - 0
Latest Pharma-News

Novartis provides update on (fevipiprant) LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma

admin - 0
Latest Pharma-News

Roche concludes getting hold of Spark Therapeutics, Inc. to reinforce presence in gene therapy

admin - 0
Latest Pharma-News

Enzalutamide Approved by FDA for metastatic castration-sensitive prostate cancer (mCSPC) Treatment

admin - 0
Latest Pharma-News

Lynparza recommended by FDA advisory committee for 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer, not Progressed on Platinum-Based Chemotherapy

admin - 0
Latest Pharma-News

Takeda collaborates with MiTest Health to Launch Innovative Disease Risk Prediction Tool to Redefine Crohn’s Disease Management

admin - 0
Latest Pharma-News

Horizon Therapeutics first FDA-approved medicine Teprotumumab for the Treatment of Thyroid Eye Disease (TED)

admin - 0
Latest Pharma-News

U.S. FDA Approved Avadel’s Nouress™ (AV001), a Cysteine Hydrochloride Injection for Treating Neonate Patients Requiring Total Parental Nutrition (TPN)

admin - 0
1...135136137...145Page 136 of 145
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved